The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999)

被引：0
|
作者：
Vaillancourt, M
Irlbeck, D
Smith, T
Coombs, RW
Swanstrom, R
机构：
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1999年 / 15卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：949 / 949
页数：1
相关论文
共 50 条
  • [1] The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance
    Vaillancourt, M
    Irlbeck, D
    Smith, T
    Coombs, RW
    Swanstrom, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (04) : 355 - 363
  • [2] PATTERNS OF SPECIFIC MUTATIONS IN HIV-1 PROTEASE THAT CONFER RESISTANCE TO A PANEL OF PROTEASE INHIBITORS
    MO, HM
    MARKOWITZ, M
    HO, DM
    DIAMOND, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 195 - 195
  • [3] HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Fessel, W. Jeffrey
    Kaufman, David
    Towner, William
    Troia, Paolo
    Ruane, Peter
    Hellinger, James
    Shirvani, Vivian
    Zolopa, Andrew
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4253 - 4261
  • [4] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Fun, Axel
    van Maarseveen, Noortje M.
    Pokorna, Jana
    Maas, Renee E. M.
    Schipper, Pauline J.
    Konvalinka, Jan
    Nijhuis, Monique
    RETROVIROLOGY, 2011, 8
  • [5] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Axel Fun
    Noortje M van Maarseveen
    Jana Pokorná
    Renée EM Maas
    Pauline J Schipper
    Jan Konvalinka
    Monique Nijhuis
    Retrovirology, 8
  • [6] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 : S144 - S144
  • [7] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S144 - S144
  • [8] HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
    Pieniazek, D
    Rayfield, M
    Hu, DJ
    Nkengasong, JN
    Soriano, V
    Heneine, W
    Zeh, C
    Agwale, SM
    Wambebe, C
    Odama, L
    Wiktor, SZ
    Kalish, ML
    AIDS, 2004, 18 (03) : 495 - 502
  • [9] Mutations in the HIV-1 3′-Polypurine Tract Can Confer Dolutegravir Resistance
    Dekker, Jose G.
    Klaver, Bep
    Berkhout, Ben
    Das, Atze T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [10] The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients
    Karmochkine, M
    Mohamed, AS
    Piketty, C
    Ginsburg, C
    Raguin, G
    Schneider-Fauveau, V
    Gutmann, L
    Kazatchkine, MD
    Belec, L
    ANTIVIRAL RESEARCH, 2000, 47 (03) : 179 - 188
12345